Azimilide: another effort to prevent implantable cardioverter-defibrillator shocks and their sequelae why it is important and how it works

J Am Coll Cardiol. 2008 Sep 23;52(13):1084-5. doi: 10.1016/j.jacc.2008.07.003.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use*
  • Arrhythmias, Cardiac / prevention & control*
  • Defibrillators, Implantable* / adverse effects
  • Humans
  • Hydantoins
  • Imidazolidines / therapeutic use*
  • Piperazines / therapeutic use*

Substances

  • Anti-Arrhythmia Agents
  • Hydantoins
  • Imidazolidines
  • Piperazines
  • azimilide